Vericel Stock Price, News & Analysis (NASDAQ:VCEL)

$6.95 0.00 (0.00 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$6.95
Today's Range$6.80 - $7.20
52-Week Range$2.35 - $8.25
Volume311,700 shs
Average Volume771,289 shs
Market Capitalization$242.61 million
P/E Ratio-8.04
Dividend YieldN/A
Beta3.34

About Vericel (NASDAQ:VCEL)

Vericel logoVericel Corporation, formerly Aastrom Biosciences, Inc., is a commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. The Company operates through the research, product development, manufacture and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases segment. Its autologous cell therapy products include Carticel (autologous cultured chondrocytes), which is an autologous chondrocyte implant for the treatment of cartilage defects in the knee, and Epicel (cultured epidermal autografts), which is a permanent skin replacement for the treatment of patients with deep-dermal or full-thickness burns. The Company is developing MACI, which is a third-generation autologous chondrocyte implant and ixmyelocel-T, which is a patient-specific multicellular therapy.

Receive VCEL News and Ratings via Email

Sign-up to receive the latest news and ratings for VCEL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biopharmaceuticals
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:VCEL
CUSIPN/A
Phone+1-734-9305555

Debt

Debt-to-Equity Ratio0.44%
Current Ratio2.50%
Quick Ratio2.22%

Price-To-Earnings

Trailing P/E Ratio-8.03920454545455
Forward P/E Ratio-11.58
P/E GrowthN/A

Sales & Book Value

Annual Sales$54.38 million
Price / Sales4.46
Cash FlowN/A
Price / CashN/A
Book Value($0.43) per share
Price / Book-16.16

Profitability

Trailing EPS($0.88)
Net Income$-19,560,000.00
Net Margins-45.11%
Return on Equity-265.45%
Return on Assets-52.01%

Miscellaneous

Employees202
Outstanding Shares34,910,000

Vericel (NASDAQ:VCEL) Frequently Asked Questions

What is Vericel's stock symbol?

Vericel trades on the NASDAQ under the ticker symbol "VCEL."

How were Vericel's earnings last quarter?

Vericel Corp (NASDAQ:VCEL) posted its quarterly earnings results on Tuesday, November, 7th. The biotechnology company reported ($0.16) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.17) by $0.01. The biotechnology company had revenue of $14.26 million for the quarter. Vericel had a negative return on equity of 265.45% and a negative net margin of 45.11%. View Vericel's Earnings History.

When will Vericel make its next earnings announcement?

Vericel is scheduled to release their next quarterly earnings announcement on Friday, March, 9th 2018. View Earnings Estimates for Vericel.

Where is Vericel's stock going? Where will Vericel's stock price be in 2018?

3 Wall Street analysts have issued 1-year target prices for Vericel's shares. Their forecasts range from $6.00 to $9.00. On average, they anticipate Vericel's share price to reach $7.67 in the next year. View Analyst Ratings for Vericel.

Are investors shorting Vericel?

Vericel saw a decrease in short interest during the month of January. As of January 12th, there was short interest totalling 1,093,372 shares, a decrease of 23.5% from the December 29th total of 1,430,058 shares. Based on an average daily trading volume, of 1,001,242 shares, the short-interest ratio is presently 1.1 days. Approximately 3.1% of the company's shares are sold short.

Who are some of Vericel's key competitors?

Who are Vericel's key executives?

Vericel's management team includes the folowing people:

  • Robert L Zerbe M.D., Independent Chairman of the Board (Age 66)
  • Dominick C. Colangelo, President, Chief Executive Officer, Director (Age 52)
  • Gerard J. Michel, Chief Financial Officer, Vice President - Corporate Development (Age 51)
  • Daniel R. Orlando, Chief Operating Officer, Chief Commercial Officer (Age 49)
  • Ross Tubo, Chief Scientific Officer (Age 55)
  • David Recker M.D., Chief Medical Officer (Age 58)
  • Steven C. Gilman Ph.D., Director (Age 64)
  • Heidi Hagen, Director (Age 46)
  • Kevin F. McLaughlin, Director (Age 60)
  • Paul Kevin Wotton Ph.D., Director (Age 56)

Who owns Vericel stock?

Vericel's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Consonance Capital Management LP (9.69%), Archon Capital Management LLC (9.25%), RTW Investments LP (3.74%), First Washington CORP (2.32%), Perkins Capital Management Inc. (1.66%) and Kopp Investment Advisors LLC (0.84%). View Institutional Ownership Trends for Vericel.

Who sold Vericel stock? Who is selling Vericel stock?

Vericel's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, EAM Investors LLC and Millennium Management LLC. View Insider Buying and Selling for Vericel.

Who bought Vericel stock? Who is buying Vericel stock?

Vericel's stock was purchased by a variety of institutional investors in the last quarter, including RTW Investments LP, Archon Capital Management LLC, Consonance Capital Management LP, Kopp Investment Advisors LLC, First Washington CORP, Broadfin Capital LLC, Wells Fargo & Company MN and Geode Capital Management LLC. View Insider Buying and Selling for Vericel.

How do I buy Vericel stock?

Shares of Vericel can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Vericel's stock price today?

One share of Vericel stock can currently be purchased for approximately $6.95.

How big of a company is Vericel?

Vericel has a market capitalization of $242.61 million and generates $54.38 million in revenue each year. The biotechnology company earns $-19,560,000.00 in net income (profit) each year or ($0.88) on an earnings per share basis. Vericel employs 202 workers across the globe.

How can I contact Vericel?

Vericel's mailing address is 64 Sidney St, CAMBRIDGE, MA 02139-4170, United States. The biotechnology company can be reached via phone at +1-734-9305555 or via email at [email protected]


MarketBeat Community Rating for Vericel (VCEL)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  151 (Vote Outperform)
Underperform Votes:  160 (Vote Underperform)
Total Votes:  311
MarketBeat's community ratings are surveys of what our community members think about Vericel and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Vericel (NASDAQ:VCEL) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $7.67$7.67$6.33$6.33
Price Target Upside: 29.94% upside29.94% upside5.56% upside89.05% upside

Vericel (NASDAQ:VCEL) Consensus Price Target History

Price Target History for Vericel (NASDAQ:VCEL)

Vericel (NASDAQ:VCEL) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/2/2018BTIG ResearchSet Price TargetBuy$8.00LowView Rating Details
1/2/2018Piper Jaffray CompaniesReiterated RatingOverweight$9.00HighView Rating Details
3/13/2017Needham & Company LLCReiterated RatingBuy -> Buy$9.00 -> $6.00HighView Rating Details
4/5/2016Bank of AmericaDowngradeBuy -> NeutralN/AView Rating Details
3/12/2016Ladenburg Thalmann Financial ServicesReiterated RatingBuyN/AView Rating Details
(Data available from 2/23/2016 forward)

Earnings

Vericel (NASDAQ:VCEL) Earnings History and Estimates Chart

Earnings by Quarter for Vericel (NASDAQ:VCEL)

Vericel (NASDAQ VCEL) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/9/2018        
11/7/2017Q3 2017($0.17)($0.16)$14.26 millionViewN/AView Earnings Details
8/9/2017Q2 2017($0.24)($0.08)$16.95 millionViewListenView Earnings Details
5/10/2017Q1 2017($0.19)($0.31)$9.36 millionViewN/AView Earnings Details
3/10/2017Q4 2016($0.22)($0.14)$16.52 millionViewN/AView Earnings Details
11/7/2016Q3($0.28)($0.38)$10.93 millionViewListenView Earnings Details
8/8/2016Q2 2016($0.21)$12.82 millionViewN/AView Earnings Details
5/10/2016Q116($0.25)($0.08)$11.60 million$14.10 millionViewListenView Earnings Details
3/14/2016Q415($0.15)($0.28)$17.36 million$15.40 millionViewListenView Earnings Details
11/13/2015Q315($0.21)($0.26)$10.50 million$11.30 millionViewListenView Earnings Details
8/12/2015Q215($0.13)($0.16)$11.31 million$13.60 millionViewListenView Earnings Details
5/14/2015Q115($0.14)($0.27)$11.10 million$10.80 millionViewListenView Earnings Details
3/23/2015Q414($0.47)($0.17)$10.70 million$14.70 millionViewListenView Earnings Details
11/13/2014Q314($0.66)($0.52)$6.73 million$9.66 millionViewN/AView Earnings Details
8/14/2014Q214($1.59)($0.94)$2.50 million$4.43 millionViewN/AView Earnings Details
5/15/2014Q114($0.92)($1.26)ViewN/AView Earnings Details
3/13/2014Q413($1.34)($0.97)$0.02 million$0.01 millionViewN/AView Earnings Details
11/12/2013Q3($2.02)($0.06)ViewListenView Earnings Details
8/7/2013Q2 2013($2.40)($2.20)ViewN/AView Earnings Details
5/8/2013Q1 2013($0.19)($0.15)$0.01 millionViewN/AView Earnings Details
3/18/2013Q4 2012($4.60)($4.00)ViewN/AView Earnings Details
11/8/2012Q3 2012($4.80)($4.40)ViewN/AView Earnings Details
8/7/2012Q2 2012($4.60)($5.40)ViewN/AView Earnings Details
5/10/2012Q1 2012($4.00)($4.56)ViewN/AView Earnings Details
3/12/2012Q4 2011($3.80)($4.06)ViewN/AView Earnings Details
11/8/2011Q3 2011($3.60)($1.00)ViewN/AView Earnings Details
8/15/2011Q2 2011($3.40)($3.88)ViewN/AView Earnings Details
5/16/2011Q1 2011($3.80)($2.58)ViewN/AView Earnings Details
2/28/2011Q4 2010($3.40)($8.86)ViewN/AView Earnings Details
11/8/2010Q3 2010($3.60)($4.12)ViewN/AView Earnings Details
8/17/2010Q2 2010($2.80)($3.62)ViewN/AView Earnings Details
5/10/2010Q1 2010($3.18)ViewN/AView Earnings Details
2/10/2010Q4 2009($4.16)ViewN/AView Earnings Details
11/6/2009Q3 2009($3.68)ViewN/AView Earnings Details
9/14/2009Q2 2009($4.80)ViewN/AView Earnings Details
5/8/2009Q1 2009($4.32)ViewN/AView Earnings Details
2/6/2009Q4 2008($4.80)ViewN/AView Earnings Details
11/7/2008Q3 2008($4.64)ViewN/AView Earnings Details
8/29/2008Q2 2008($6.40)($5.92)ViewN/AView Earnings Details
5/12/2008Q1 2008($6.40)($6.08)ViewN/AView Earnings Details
2/8/2008Q4 2007($6.40)($6.40)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Vericel (NASDAQ:VCEL) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.6 EPS
Next Year EPS Consensus Estimate: $-0.36 EPS

Dividends

Dividend History for Vericel (NASDAQ:VCEL)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Vericel (NASDAQ VCEL) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.30%
Institutional Ownership Percentage: 32.08%
Insider Trades by Quarter for Vericel (NASDAQ:VCEL)
Institutional Ownership by Quarter for Vericel (NASDAQ:VCEL)

Vericel (NASDAQ VCEL) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/28/2016Consonance Capital ManagementMajor ShareholderSell120,000$5.39$646,800.00View SEC Filing  
9/16/2014Daniel OrlandoCOOBuy9,804$2.55$25,000.20View SEC Filing  
9/16/2014Dominick ColangeloCEOBuy20,000$2.55$51,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Vericel (NASDAQ VCEL) News Headlines

Source:
DateHeadline
Vericel to Report Fourth-Quarter and Full-Year 2017 Financial Results on March 5, 2018Vericel to Report Fourth-Quarter and Full-Year 2017 Financial Results on March 5, 2018
finance.yahoo.com - February 22 at 9:06 AM
Zacks: Analysts Anticipate Vericel Corp (VCEL) to Post -$0.10 EPSZacks: Analysts Anticipate Vericel Corp (VCEL) to Post -$0.10 EPS
www.americanbankingnews.com - February 9 at 1:12 AM
Vericel to Present at the BIO CEO & Investor ConferenceVericel to Present at the BIO CEO & Investor Conference
finance.yahoo.com - February 5 at 9:16 AM
Vericel (VCEL) Upgraded to Hold at ValuEngineVericel (VCEL) Upgraded to Hold at ValuEngine
www.americanbankingnews.com - February 4 at 9:02 AM
Vericel to Present at the 7th Annual Leerink Partners Global Healthcare Conference - GlobeNewswire (press release)Vericel to Present at the 7th Annual Leerink Partners Global Healthcare Conference - GlobeNewswire (press release)
globenewswire.com - February 3 at 4:21 PM
Vericel to Present at the 7th Annual Leerink Partners Global Healthcare ConferenceVericel to Present at the 7th Annual Leerink Partners Global Healthcare Conference
finance.yahoo.com - February 1 at 9:23 AM
Vericel Corp (VCEL) Short Interest UpdateVericel Corp (VCEL) Short Interest Update
www.americanbankingnews.com - January 29 at 1:40 AM
Head to Head Review: Alimera Sciences (ALIM) & Vericel (VCEL)Head to Head Review: Alimera Sciences (ALIM) & Vericel (VCEL)
www.americanbankingnews.com - January 28 at 5:18 AM
Analyzing Vericel (VCEL) and Mediwound (MDWD)Analyzing Vericel (VCEL) and Mediwound (MDWD)
www.americanbankingnews.com - January 24 at 5:42 PM
Vericel Corp (VCEL) Expected to Post Earnings of -$0.10 Per ShareVericel Corp (VCEL) Expected to Post Earnings of -$0.10 Per Share
www.americanbankingnews.com - January 23 at 1:18 AM
Vericel Corp (VCEL) Short Interest Up 37.6% in DecemberVericel Corp (VCEL) Short Interest Up 37.6% in December
www.americanbankingnews.com - January 14 at 2:32 AM
Vericel to Present at the 20th Annual Needham Growth Conference - GlobeNewswire (press release)Vericel to Present at the 20th Annual Needham Growth Conference - GlobeNewswire (press release)
globenewswire.com - January 11 at 10:55 AM
Vericel to Present at the 20th Annual Needham Growth ConferenceVericel to Present at the 20th Annual Needham Growth Conference
finance.yahoo.com - January 10 at 10:36 AM
UPDATE: Vericel Corporation (VCEL) PT Raised to $9 at Piper ... - StreetInsider.comUPDATE: Vericel Corporation (VCEL) PT Raised to $9 at Piper ... - StreetInsider.com
www.streetinsider.com - January 2 at 5:10 PM
Vericel Initiates Collaboration with Innovative Cellular Therapeutics ... - GlobeNewswire (press release)Vericel Initiates Collaboration with Innovative Cellular Therapeutics ... - GlobeNewswire (press release)
globenewswire.com - January 2 at 5:10 PM
BRIEF-Vericel Initiates Collaboration with Innovative Cellular TherapeuticsBRIEF-Vericel Initiates Collaboration with Innovative Cellular Therapeutics
www.reuters.com - January 2 at 10:21 AM
Vericel Corp. :VCEL-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018Vericel Corp. :VCEL-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018
finance.yahoo.com - January 1 at 10:20 AM
Zacks: Analysts Expect Vericel Corp (VCEL) to Post -$0.10 EPSZacks: Analysts Expect Vericel Corp (VCEL) to Post -$0.10 EPS
www.americanbankingnews.com - December 20 at 1:18 PM
BRIEF-Vericel Enters Into Expanded $25 Million Debt Facilities With Silicon Valley Bank And Midcap FinancialBRIEF-Vericel Enters Into Expanded $25 Million Debt Facilities With Silicon Valley Bank And Midcap Financial
www.reuters.com - December 7 at 10:57 AM
Facilities Include a $15 Million Term Loan and $10 Million Revolving Line of CreditFacilities Include a $15 Million Term Loan and $10 Million Revolving Line of Credit
globenewswire.com - December 7 at 10:57 AM
Vericel Enters into Expanded $25 Million Debt Facilities with Silicon Valley Bank and MidCap Financial to Support Accelerating MACI Uptake and Increased Epicel UsageVericel Enters into Expanded $25 Million Debt Facilities with Silicon Valley Bank and MidCap Financial to Support Accelerating MACI Uptake and Increased Epicel Usage
finance.yahoo.com - December 7 at 10:57 AM
How Vericel Corporation’s (VCEL) EPS Growth Stacks Up Against Industry PerformanceHow Vericel Corporation’s (VCEL) EPS Growth Stacks Up Against Industry Performance
finance.yahoo.com - December 7 at 10:57 AM
-$0.10 Earnings Per Share Expected for Vericel Corporation (VCEL) This Quarter-$0.10 Earnings Per Share Expected for Vericel Corporation (VCEL) This Quarter
www.americanbankingnews.com - December 2 at 5:28 PM
Vericel (VCEL) Lowered to "Sell" at ValuEngineVericel (VCEL) Lowered to "Sell" at ValuEngine
www.americanbankingnews.com - December 2 at 12:40 AM
Vericel to Present at 29th Annual Piper Jaffray Healthcare ConferenceVericel to Present at 29th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 18 at 9:59 AM
Vericel Corporation (VCEL): Time For A Financial Health CheckVericel Corporation (VCEL): Time For A Financial Health Check
finance.yahoo.com - November 18 at 9:59 AM
 Brokerages Anticipate Vericel Corporation (VCEL) to Announce -$0.13 Earnings Per Share Brokerages Anticipate Vericel Corporation (VCEL) to Announce -$0.13 Earnings Per Share
www.americanbankingnews.com - November 14 at 7:58 AM
Critical Contrast: Kadmon Holdings (KDMN) & Vericel Corporation (VCEL)Critical Contrast: Kadmon Holdings (KDMN) & Vericel Corporation (VCEL)
www.americanbankingnews.com - November 13 at 5:15 AM
ETFs with exposure to Vericel Corp. : November 8, 2017ETFs with exposure to Vericel Corp. : November 8, 2017
finance.yahoo.com - November 9 at 9:23 AM
Edited Transcript of VCEL earnings conference call or presentation 7-Nov-17 1:00pm GMTEdited Transcript of VCEL earnings conference call or presentation 7-Nov-17 1:00pm GMT
finance.yahoo.com - November 7 at 8:21 PM
Vericel Corporation (VCEL) Issues  Earnings ResultsVericel Corporation (VCEL) Issues Earnings Results
www.americanbankingnews.com - November 7 at 4:20 PM
Vericels (VCEL) CEO Dominick Colangelo on Q3 2017 Results - Earnings Call TranscriptVericel's (VCEL) CEO Dominick Colangelo on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 7 at 3:18 PM
Vericel Reports Third-Quarter 2017 Financial Results - GlobeNewswire (press release)Vericel Reports Third-Quarter 2017 Financial Results - GlobeNewswire (press release)
globenewswire.com - November 7 at 12:59 PM
Vericel Corporation to Host Earnings CallVericel Corporation to Host Earnings Call
finance.yahoo.com - November 7 at 12:59 PM
Vericel Reports Third-Quarter 2017 Financial ResultsVericel Reports Third-Quarter 2017 Financial Results
finance.yahoo.com - November 7 at 12:59 PM
Head to Head Contrast: Novus Therapeutics (NVUS) & Vericel Corporation (VCEL)Head to Head Contrast: Novus Therapeutics (NVUS) & Vericel Corporation (VCEL)
www.americanbankingnews.com - November 6 at 11:04 PM
Vericel Corporation (VCEL) & KalVista Pharmaceuticals (KALV) Financial AnalysisVericel Corporation (VCEL) & KalVista Pharmaceuticals (KALV) Financial Analysis
www.americanbankingnews.com - October 31 at 11:10 PM
Analyzing Anika Therapeutics (ANIK) & Vericel Corporation (VCEL)Analyzing Anika Therapeutics (ANIK) & Vericel Corporation (VCEL)
www.americanbankingnews.com - October 31 at 10:00 AM
Vericel Corporation (VCEL) Scheduled to Post Quarterly Earnings on TuesdayVericel Corporation (VCEL) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - October 31 at 7:58 AM
ETFs with exposure to Vericel Corp. : October 26, 2017ETFs with exposure to Vericel Corp. : October 26, 2017
finance.yahoo.com - October 26 at 12:04 PM
Vericel to Host Third-Quarter 2017 Earnings Webcast and ... - GlobeNewswire (press release)Vericel to Host Third-Quarter 2017 Earnings Webcast and ... - GlobeNewswire (press release)
globenewswire.com - October 25 at 8:56 PM
Vericel to Host Third-Quarter 2017 Earnings Webcast and Conference Call on November 7, 2017Vericel to Host Third-Quarter 2017 Earnings Webcast and Conference Call on November 7, 2017
finance.yahoo.com - October 25 at 8:56 PM
Vericel Corporation (VCEL) versus Peregrine Pharmaceuticals (PPHM) Head-To-Head SurveyVericel Corporation (VCEL) versus Peregrine Pharmaceuticals (PPHM) Head-To-Head Survey
www.americanbankingnews.com - October 25 at 7:12 AM
First Week Of December 15th Options Trading For Vericel (VCEL)First Week Of December 15th Options Trading For Vericel (VCEL)
www.thestreet.com - October 24 at 11:56 AM
ETFs with exposure to Vericel Corp. : October 16, 2017ETFs with exposure to Vericel Corp. : October 16, 2017
finance.yahoo.com - October 17 at 8:42 AM
VIVUS (VVUS) vs. Vericel Corporation (VCEL) Head to Head ContrastVIVUS (VVUS) vs. Vericel Corporation (VCEL) Head to Head Contrast
www.americanbankingnews.com - October 7 at 2:22 PM
Vericel Surrenders 6 Days Of GainsVericel Surrenders 6 Days Of Gains
www.benzinga.com - October 6 at 12:22 PM
Vericel Provides Business Updates at 2017 Cell & Gene Meeting on the MesaVericel Provides Business Updates at 2017 Cell & Gene Meeting on the Mesa
finance.yahoo.com - October 6 at 12:22 PM
 Brokerages Anticipate Vericel Corporation (VCEL) Will Post Earnings of -$0.17 Per Share Brokerages Anticipate Vericel Corporation (VCEL) Will Post Earnings of -$0.17 Per Share
www.americanbankingnews.com - October 5 at 8:22 PM
Reviewing Vericel Corporation (VCEL) & Its CompetitorsReviewing Vericel Corporation (VCEL) & Its Competitors
www.americanbankingnews.com - October 5 at 2:14 AM

SEC Filings

Vericel (NASDAQ:VCEL) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Vericel (NASDAQ:VCEL) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Vericel (NASDAQ VCEL) Stock Chart for Friday, February, 23, 2018

Loading chart…

This page was last updated on 2/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.